U
U.S. Stem Cell, Inc. USRM
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2022 09/30/2022 06/30/2022 03/31/2022 12/31/2021
Net Income -2.86M -2.93M -3.04M -3.46M -3.29M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 2.27M 2.19M 2.24M 2.35M 2.20M
Change in Net Operating Assets 285.20K 259.50K 179.60K 312.00K 28.10K
Cash from Operations -304.90K -478.50K -619.80K -804.20K -1.06M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 213.20K 210.70K 234.70K 134.00K 856.00K
Total Debt Repaid -27.60K -42.30K -52.40K -59.30K -52.10K
Issuance of Common Stock 85.00K 310.00K 310.00K 300.00K 275.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 270.60K 478.40K 492.30K 374.70K 1.08M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -34.20K -100.00 -127.50K -429.50K 20.90K
Weiss Ratings